RENDU OSLER DISEASE

Clinical trials for RENDU OSLER DISEASE explained in plain language.

Never miss a new study

Get alerted when new RENDU OSLER DISEASE trials appear

Sign up with your email to follow new studies for RENDU OSLER DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 2

Blood thinners in HHT: a risky balancing act under the microscope

Disease control Recruiting now

This study follows 100 adults with hereditary hemorrhagic telangiectasia (HHT) who start taking blood thinners (anticoagulants or antiplatelets). Researchers compare the three months before treatment to the first three months on treatment, tracking bleeding events, iron levels, a…

Matched conditions: RENDU OSLER DISEASE

Phase: NA • Sponsor: University Hospital, Clermont-Ferrand • Aim: Disease control

Last updated Jul 12, 2026 00:00 UTC

RENDU OSLER DISEASE

Get alerted when new RENDU OSLER DISEASE trials appear

Blood thinners in HHT: a risky balancing act under the microscope